Previous studies have shown that ovocystatin improves cognitive function in young rats, prevents aging-related cognitive impairment in older animals, and induces changes in the expression of Alzheimer’s disease—Aβ and tau proteins in the APP/PS1 mice model. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.